DGST Funded Research Project

BioPrintX is currently engaged in a newly initiated research project funded by the Directorate General of Science & Technology (DGST), Government of Khyber Pakhtunkhwa.

Project Title: Development of Artificial Skin & Tissue Substitutes Based on 3D Bio‑Printed Advanced Materials
Project ID: DGST/BSTICE R&D‑Cons/2024‑2025/1332

This project aims to develop innovative bioprinted tissue constructs and advanced biomaterial‑based solutions for regenerative medicine and wound management, contributing to sustainable healthcare innovation in Pakistan.

Read more about DGST: https://dost.kp.gov.pk/

 
 

Blanket of Hope

Next-Generation Emergency Wound Care

Ink for Life

Advanced Bioinks for Tissue Engineering

Precision Wound Dressing

Personalized Wound-Healing Patch

Smart Healing Drape

Universal Dressing for Everyday Healing

Next Generation Cosmetics

Regenerative Bioactive Skincare Line

Artificial Skin & Tissue Substitutes

Advancing next-generation bioengineered skin using 3D bioprinting and regenerative biomaterials for safer, faster wound healing.

Bioinks & Cell Culture Innovation

Developing optimized bioinks and advanced 2D/3D cell culture systems to support tissue formation, healing, and biomedical testing.

Smart Regenerative Wound Dressings

Creating personalized patches, smart drapes, and emergency wound-care products that accelerate healing and reduce complications.

10+

Core Research & Technical Team Members

55

Research Grants Awarded (Funded by DGST & Collaborative Agencies)

04

Innovative Biomedical Products

About BioPrintX

BioPrintX is a biotechnology and regenerative medicine startup dedicated to developing next-generation solutions in wound healing, artificial skin, and tissue engineering. Our research integrates advanced biomaterials, 3D/4D bioprinting, and translational science to create practical, high-impact healthcare innovations for patients and clinicians.

Our work spans fundamental research to real-world biomedical products, supported by strong academic collaboration with PAF-IAST and competitive funding from DGST.

With PKR 55 million in funded research projects and four innovative biomedical products under development, BioPrintX is shaping the future of regenerative medicine in Pakistan. Our mission is to translate cutting-edge laboratory research into accessible, life-changing healthcare solutions.